Integrated Historical Income Statement

IDHC Stock

0.41 0.01 2.38%

Historical analysis of Integrated Diagnostics income statement accounts such as Selling And Marketing Expenses of 92 M or Total Revenue of 2.3 B can show how well Integrated Diagnostics Holdings performed in making a profits. Evaluating Integrated Diagnostics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Integrated Diagnostics's future profits or losses.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Integrated Diagnostics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Integrated Diagnostics is a good buy for the upcoming year.

Net Income Gross Profit

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Integrated Diagnostics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Integrated Income Statement Analysis

Integrated Diagnostics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Integrated Diagnostics shareholders. The income statement also shows Integrated investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Integrated Diagnostics Income Statement Chart

At this time, Integrated Diagnostics' Minority Interest is comparatively stable compared to the past year. Tax Provision is likely to gain to about 339.1 M in 2024, whereas Selling And Marketing Expenses is likely to drop slightly above 92 M in 2024.

Selling General Administrative Selling And Marketing Expenses Total Revenue Gross Profit Total Operating Expenses Tax Provision

Total Revenue

Total revenue comprises all receipts Integrated Diagnostics generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Integrated Diagnostics Holdings minus its cost of goods sold. It is profit before Integrated Diagnostics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.

Most accounts from Integrated Diagnostics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Integrated Diagnostics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Integrated Diagnostics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Gross Profit	2.8B	1.5B	1.5B	1.1B
Total Revenue	5.2B	3.6B	4.1B	2.3B

Gross Profit Total Revenue

Integrated Diagnostics income statement Correlations

	Depreciation And Amortization	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Interest Expense	Net Income From Continuing Ops	Minority Interest	Tax Provision	Net Interest Income	Interest Income	Reconciled Depreciation
Depreciation And Amortization		0.45	0.64	0.66	0.53	0.9	0.43	0.44	0.53	0.89	0.91	0.4	-0.32	0.4	0.44	0.93	0.39	-0.15	0.51	-0.93	0.66	0.88
Selling General Administrative	0.45		0.71	0.67	0.63	0.63	0.52	0.54	0.57	0.62	0.66	0.52	-0.22	0.53	0.54	0.64	0.51	0.27	0.5	-0.51	0.59	0.68
Selling And Marketing Expenses	0.64	0.71		0.89	0.81	0.82	0.76	0.74	0.79	0.83	0.77	0.7	-0.56	0.73	0.72	0.84	0.68	0.24	0.66	-0.62	0.85	0.88
Total Revenue	0.66	0.67	0.89		0.97	0.86	0.92	0.93	0.96	0.88	0.77	0.9	-0.4	0.91	0.92	0.83	0.89	-0.11	0.89	-0.56	0.94	0.87
Gross Profit	0.53	0.63	0.81	0.97		0.79	0.98	0.99	1.0	0.81	0.67	0.98	-0.33	0.98	0.98	0.74	0.97	-0.12	0.96	-0.43	0.92	0.73
Other Operating Expenses	0.9	0.63	0.82	0.86	0.79		0.71	0.72	0.77	1.0	0.98	0.68	-0.35	0.7	0.7	0.98	0.68	-0.06	0.73	-0.83	0.86	0.92
Operating Income	0.43	0.52	0.76	0.92	0.98	0.71		0.99	0.98	0.74	0.57	0.99	-0.38	0.99	0.99	0.66	0.98	-0.13	0.97	-0.31	0.91	0.63
Ebit	0.44	0.54	0.74	0.93	0.99	0.72	0.99		0.99	0.75	0.58	1.0	-0.28	1.0	1.0	0.65	0.99	-0.11	0.97	-0.32	0.9	0.63
Ebitda	0.53	0.57	0.79	0.96	1.0	0.77	0.98	0.99		0.8	0.64	0.98	-0.32	0.98	0.99	0.72	0.97	-0.14	0.97	-0.41	0.92	0.72
Cost Of Revenue	0.89	0.62	0.83	0.88	0.81	1.0	0.74	0.75	0.8		0.96	0.72	-0.36	0.73	0.74	0.98	0.71	-0.07	0.76	-0.81	0.89	0.91
Total Operating Expenses	0.91	0.66	0.77	0.77	0.67	0.98	0.57	0.58	0.64	0.96		0.54	-0.31	0.56	0.57	0.97	0.53	-0.03	0.59	-0.88	0.76	0.9
Income Before Tax	0.4	0.52	0.7	0.9	0.98	0.68	0.99	1.0	0.98	0.72	0.54		-0.25	1.0	0.99	0.61	1.0	-0.12	0.98	-0.27	0.88	0.58
Total Other Income Expense Net	-0.32	-0.22	-0.56	-0.4	-0.33	-0.35	-0.38	-0.28	-0.32	-0.36	-0.31	-0.25		-0.24	-0.28	-0.43	-0.22	0.1	-0.24	0.3	-0.46	-0.48
Net Income	0.4	0.53	0.73	0.91	0.98	0.7	0.99	1.0	0.98	0.73	0.56	1.0	-0.24		0.99	0.63	1.0	-0.08	0.96	-0.28	0.89	0.59
Income Tax Expense	0.44	0.54	0.72	0.92	0.98	0.7	0.99	1.0	0.99	0.74	0.57	0.99	-0.28	0.99		0.65	0.99	-0.15	0.99	-0.32	0.89	0.62
Interest Expense	0.93	0.64	0.84	0.83	0.74	0.98	0.66	0.65	0.72	0.98	0.97	0.61	-0.43	0.63	0.65		0.6	0.01	0.67	-0.9	0.81	0.94
Net Income From Continuing Ops	0.39	0.51	0.68	0.89	0.97	0.68	0.98	0.99	0.97	0.71	0.53	1.0	-0.22	1.0	0.99	0.6		-0.12	0.97	-0.26	0.88	0.56
Minority Interest	-0.15	0.27	0.24	-0.11	-0.12	-0.06	-0.13	-0.11	-0.14	-0.07	-0.03	-0.12	0.1	-0.08	-0.15	0.01	-0.12		-0.22	-0.02	-0.14	-0.05
Tax Provision	0.51	0.5	0.66	0.89	0.96	0.73	0.97	0.97	0.97	0.76	0.59	0.98	-0.24	0.96	0.99	0.67	0.97	-0.22		-0.36	0.88	0.61
Net Interest Income	-0.93	-0.51	-0.62	-0.56	-0.43	-0.83	-0.31	-0.32	-0.41	-0.81	-0.88	-0.27	0.3	-0.28	-0.32	-0.9	-0.26	-0.02	-0.36		-0.48	-0.85
Interest Income	0.66	0.59	0.85	0.94	0.92	0.86	0.91	0.9	0.92	0.89	0.76	0.88	-0.46	0.89	0.89	0.81	0.88	-0.14	0.88	-0.48		0.79
Reconciled Depreciation	0.88	0.68	0.88	0.87	0.73	0.92	0.63	0.63	0.72	0.91	0.9	0.58	-0.48	0.59	0.62	0.94	0.56	-0.05	0.61	-0.85	0.79

Click cells to compare fundamentals

Integrated Diagnostics Account Relationship Matchups

Integrated Diagnostics income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	153.5M	185.4M	238.6M	317.3M	401.2M	421.3M
Selling General Administrative	189.5M	221.9M	198.9M	201.7M	256.1M	168.1M
Selling And Marketing Expenses	115.8M	107.2M	117.9M	157.7M	145.3M	92.0M
Total Revenue	2.2B	2.7B	5.2B	3.6B	4.1B	2.3B
Gross Profit	1.1B	1.3B	2.8B	1.5B	1.5B	1.1B
Other Operating Expenses	1.4B	1.6B	2.9B	2.7B	3.4B	3.6B
Operating Income	790.8M	985.5M	2.3B	1.2B	737.8M	765.5M
Ebit	819.1M	1.0B	2.3B	976.3M	879.0M	776.5M
Ebitda	972.6M	1.2B	2.6B	1.3B	1.3B	951.5M
Cost Of Revenue	1.1B	1.3B	2.4B	2.1B	2.6B	2.7B
Total Operating Expenses	284.3M	314.9M	517.3M	577.7M	786.6M	825.9M
Income Before Tax	758.1M	969.1M	2.2B	853.6M	737.4M	729.5M
Total Other Income Expense Net	(32.7M)	(16.5M)	(29.7M)	(317.8M)	(406K)	(426.3K)
Net Income	510.9M	594.0M	1.4B	541.1M	510.3M	464.7M
Income Tax Expense	253.6M	359.6M	739.8M	327.1M	269.0M	258.1M
Interest Expense	61.0M	67.9M	98.0M	122.7M	141.7M	148.8M
Net Income From Continuing Ops	504.5M	609.5M	1.5B	526.6M	468.4M	511.4M
Net Income Applicable To Common Shares	502.1M	510.9M	594.0M	1.4B	1.6B	1.7B
Minority Interest	144.7M	156.4M	(79.9M)	14.5M	41.9M	60.1M
Tax Provision	253.6M	359.6M	739.8M	327.1M	269.0M	339.1M
Net Interest Income	(21.0M)	(18.4M)	(4.9M)	(40.2M)	(88.2M)	(83.8M)
Interest Income	43.6M	53.1M	113.2M	95.4M	72.8M	70.1M
Reconciled Depreciation	153.5M	185.4M	238.6M	317.3M	401.2M	225.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Integrated Stock Analysis

When running Integrated Diagnostics' price analysis, check to measure Integrated Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Diagnostics is operating at the current time. Most of Integrated Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integrated Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Diagnostics' price. Additionally, you may evaluate how the addition of Integrated Diagnostics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC